GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelira Therapeutics Ltd (ASX:ZLD) » Definitions » Institutional Ownership

Zelira Therapeutics (ASX:ZLD) Institutional Ownership : 0.03% (As of Jun. 23, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zelira Therapeutics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Zelira Therapeutics's institutional ownership is 0.03%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Zelira Therapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Zelira Therapeutics's Float Percentage Of Total Shares Outstanding is 0.00%.


Zelira Therapeutics Institutional Ownership Historical Data

The historical data trend for Zelira Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zelira Therapeutics Institutional Ownership Chart

Zelira Therapeutics Historical Data

The historical data trend for Zelira Therapeutics can be seen below:

2016-04-30 2016-05-31 2016-06-30 2016-07-31 2016-08-31 2016-09-30 2018-03-31 2018-04-30 2018-05-31 2018-06-30
Institutional Ownership 0.01 0.01 0.01 0.01 0.01 0.01 0.04 0.06 0.06 0.03

Zelira Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Zelira Therapeutics (ASX:ZLD) Business Description

Traded in Other Exchanges
Address
101 St George’s Terrace, Level 3, Perth, WA, AUS, 6000
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.

Zelira Therapeutics (ASX:ZLD) Headlines

No Headlines